Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 23/2/2018
SIETES contiene 92199 citas

 1 a 20 de 657 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Campaigno EP, Kebir I, Montastruc JL, Rueter M, Maret D, Lapeyre-Mestre M, Sallerin B, Despas F. Drug-induced dental caries: a disproportionality analysis using data from VigiBase. Drug Saf 2017;40:1249-58. [Ref.ID 102146]
2.Enlace a cita original Cita con resumen
Akram Z, Abduljabbar T, Kellesarian SV, Hassan MIA, Javed F, Vohra F. Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review. Br J Clin Pharmacol 2017;83:444-54. [Ref.ID 101463]
3. Cita con resumen
Anónimo. Décongestionnants rhinopharyngés: fibrillations auriculaires. Prescrire 2017;37:24. [Ref.ID 101364]
4. Cita con resumen
Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M, Strong M, Selby P, Gittoes N. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technol Assess 2016;20:1-406. [Ref.ID 101044]
5.Tiene citas relacionadas Cita con resumen
Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo A, Alexandersen P, Zerbini CAF, Hu M-y, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C, for the ACTIVE Study Investigators. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA 2016;316:722-33. [Ref.ID 100710]
6.Tiene citas relacionadas Cita con resumen
Cappola AR, Shoback DM. Osteoporosis therapy in postmenopausal women with high risk of fracture. JAMA 2016;316:715-6. [Ref.ID 100709]
7. Cita con resumen
Ekstam AK, Elmståhl S. Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study. Clinical Interventions in Aging 2016;11:489-96. [Ref.ID 100216]
8.Enlace a cita original Cita con resumen
Anónimo. Biphosphonates: very rare osteonecrosis of external ear canal . WHO Drug Information 2016;30:48. [Ref.ID 100125]
9. Cita con resumen
Yeh MW, Zhou H, Adams AL, Ituarte PHG, Liu IA, Haigh PI. The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study. Ann Intern Med 2016:5 de abril. [Ref.ID 100114]
10. Cita con resumen
Anónimo. Riesgo de osteonecrosis mandibular asociado a la administración de aflibercept (Zaltrap) . Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2016:16 de marzo. [Ref.ID 100031]
11.Enlace a cita original Cita con resumen
Anónimo. Prevención de fracturas osteoporóticas y duración del tratamiento. Boletín Terapéutico Andaluz 2015;30:1. [Ref.ID 99827]
12. Cita con resumen
Anónimo. Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal. Drug Safety Update 2015;9:4. [Ref.ID 99748]
13.Tiene citas relacionadas Cita con resumen
Brufsky A, Mathew A. Bisphosphonates, bone, and breast cancer recurrence. Lancet 2015;386:1319-20. [Ref.ID 99582]
14. Cita con resumen
Anónimo. Consolidations de fracture retardées par des médicaments. Prescrire 2015;35:507-12. [Ref.ID 99440]
15. Cita con resumen
Anónimo. Paying a high price for cancer drugs. Lancet 2015;386:404. [Ref.ID 99395]
16.Tiene citas relacionadas Cita con resumen
Grey A, Bolland M. Web of industry, advocacy, and academia in the management of osteoporosis. BMJ 2015;351:h3170. [Ref.ID 99391]
17. Cita con resumen
Glyn-Jones S, Palmer AJR, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ. Osteoarthritis. Lancet 2015;386:376-87. [Ref.ID 99368]
18.Tiene citas relacionadas Cita con resumen
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet 2015;386:3 de octubre. [Ref.ID 99277]
19. Cita con resumen
Anónimo. Diphosphonates: pseudo-gouttes. Prescrire 2014;34:833. [Ref.ID 98466]
20.Tiene citas relacionadas
Bischoff-Ferrari HA, Meyer O. Comparative effectiveness of pharmacologic treatments to prevent fractures: is this all we need to know?. Ann Intern Med 2014;161:711-23. [Ref.ID 98329]
Seleccionar todas
 1 a 20 de 657 siguiente >>